US 9765053
Methods of treatment using selective 5-HT2A inverse agonists
granted A61KA61K31/40A61K31/445
Quick answer
US patent 9765053 (Methods of treatment using selective 5-HT2A inverse agonists) held by ACADIA Pharmaceuticals Inc. expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/40, A61K31/445, A61K31/55, A61P